Clinical Handbook of Psychotropic Drugs
Hogrefe & Huber (Verlag)
978-0-88937-200-9 (ISBN)
- Titel erscheint in neuer Auflage
- Artikel merken
Antidepressants: selective serotonin-reuptake inhibitors (SSRI); selective dopamine-reuptake inhibitors (SDRI); selective serotonin norepinephrine reuptake inhibitor (SNRI); non-selective cyclic antidepressants; noradrenergic specific serotonergic agent (NaSSA); effects of antidepressants on neurotransmitters/receptors; pharmacological effects on neurotransmitters/receptors; frequency of adverse reactions to cyclic antidepressants; monoamine oxidase inhibitors; irreversible monoamine oxidae inhibitors; frequency of adverse reactions to MAOI antidepressants; antidepressant doses; switching antidepressants; antidepressant augmentation strategies. Electroconclusive therapy (ECT). Neuroleptics (antipsychotics): "novel" neuroleptics; "conventional" neuroleptics; neuroleptic doses; effects of neuroleptics on neurotransmitters/receptors; frequency of adverse reactions to neuroleptics; comparison of depot neuroleptics; neurological effects/extrapyramidal side efffects; neuroleptic augmentation strategies. Antiparkinsonian agents: effects onextrapyramidal symptoms; comparison of antiparkinsonian agents. Anxiolytic agents: benzodiazepines; comparison of the benzodiazepines; buspirone. Hypnotic/sedatives: comparison of hypnotic/sedatives. Mood atabilizers: lithium; carbamazepine; valproate; clonazepam; L-tryptophan. Psychostimulants: comparison of the psychstimulants. Cognition enhances: comparison of acetylcholinesterase inhibitors. Sex-drive depressants. Drugs of abuse: alcohol; hallucinogens; stimulants; opiatric/narcotics; inhalants/aerosols. Anti-alcohol drugs. Naltrexone (Revia). New unapproved treatments of psychiatric disorders; adrenergic agents; calcium channel blockers; cholinergic agents; dopaminergic agents; GABA-agents; peptides; serotonergic agents; serotonin antagonists; steroid biosynthesis inhibitors; miscellaneous.
Erscheint lt. Verlag | 1.5.1998 |
---|---|
Zusatzinfo | 50tabs. |
Verlagsort | Toronto |
Sprache | englisch |
Maße | 220 x 280 mm |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
ISBN-10 | 0-88937-200-4 / 0889372004 |
ISBN-13 | 978-0-88937-200-9 / 9780889372009 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich